Evidence map›Paper›PMID 24057215›Full record

ArticleNucleic acids research2014

MiR-138 downregulates miRNA processing in HeLa cells by targeting RMND5A and decreasing Exportin-5 stability.

Jie Li, Ying Chen, Xingliang Qin, Junzhi Wen, Hongmei Ding, Wei Xia, Shaohua Li, Xueting Su, Wei Wang, Hui Li and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The Role of miR-138 in Cardiovascular Diseases.BioMed research international · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The Role of Exportin-5 in MicroRNA Biogenesis and Cancer.Genomics, proteomics & bioinformatics · 2018
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Jie LiDepartment of Biochemistry and Molecular Biology, Beijing Institute of Basic Medical Sciences, Beijing 100850, China and Key Laboratory of Gene Engineering of the Ministry of Education, State Key Laboratory for Biocontrol, Sun Yat-sen University, Guangzhou, 510275, China.
Ying Chen
Xingliang Qin
Junzhi Wen
Hongmei Ding
Wei Xia
Shaohua Li
Xueting Su
Wei Wang
Hui Li
Qiang Zhao
Tao Fang
Lianghu Qu
Ningsheng Shao
Sun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs (miRNAs) are a class of non-coding small RNAs that consist of ≈ 22 nt and are involved in several biological processes by regulating target gene expression. MiR-138 has many biological functions and is often downregulated in cancers. Our results showed that overexpression of miR-138 downregulated target RMND5A (required for meiotic nuclear division 5 homolog A) and reduced Exportin-5 stability, which results in decreased levels of pre-miRNA nuclear export in HeLa cells. We also found that miR-138 could significantly inhibit HeLa cell migration by targeting RMND5A. Our study therefore identifies miR-138-RMND5A-Exportin-5 as a previously unknown miRNA processing regulatory pathway in HeLa cells.

Indexed as

Down-RegulationRNA Processing, Post-TranscriptionalActive Transport, Cell NucleusCarrier ProteinsCell MovementCell NucleusHeLa CellsHumansKaryopherinsMicroRNAsProtein StabilityRNA PrecursorsCarrier ProteinsKaryopherinsMicroRNAsMIRN138 microRNA, humanRMND5A protein, humanRNA PrecursorsXPO5 protein, human

Identifiers

PMID24057215
PMCPMC3874158
OpenAlexW2155451479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.